Market Insights Health OTC Pharmaceuticals

Digestives & Intestinal Remedies - Americas

Americas

In the year 2024, the Digestives & Intestinal Remedies market market in the Americas region recorded a significant revenue of US$4.26bn.
This market is projected to experience a steady annual growth rate of 2.71% between 2024 and 2029 (CAGR 2024-2029).
When compared on a global scale, in China emerged as the leading contributor in terms of revenue, generating a substantial amount of US$4,408.00m in 2024.
In relation to the total population, the per person revenue in the Americas market reached US$4.19 in 2024.
In the Americas, there is a growing trend of consumers seeking natural and herbal digestive remedies, leading to an increase in the demand for plant-based digestive supplements.

Key regions: Brazil, India, United Kingdom, Germany, China

Market

Region

Region comparison

Currency

Analyst Opinion

The Digestives & Intestinal Remedies market in Americas is experiencing steady growth due to increasing customer preferences for natural and herbal remedies, as well as a rising awareness of digestive health.

Customer preferences: Customers in the Americas are increasingly seeking natural and herbal remedies for digestive issues. This preference is driven by a growing concern for the potential side effects of pharmaceutical drugs and a desire for more holistic approaches to healthcare. As a result, there has been a surge in demand for natural digestive supplements and probiotics, which are believed to promote gut health and improve digestion.

Trends in the market: One of the key trends in the Digestives & Intestinal Remedies market in the Americas is the growing popularity of probiotics. Probiotics are live bacteria and yeasts that are beneficial for digestive health. They are commonly found in yogurt and other fermented foods, but are also available in the form of supplements. The increasing awareness of the importance of gut health has led to a significant rise in the demand for probiotic products.Another trend in the market is the rising popularity of digestive enzymes. Digestive enzymes are substances that help break down food and improve digestion. They are particularly useful for individuals with digestive disorders such as lactose intolerance or pancreatic insufficiency. The demand for digestive enzyme supplements has been increasing as more people become aware of these conditions and seek solutions to improve their digestion.

Local special circumstances: In the Americas, there is a diverse population with different dietary habits and lifestyles. This diversity creates a demand for a wide range of digestive remedies to cater to the specific needs of different individuals. For example, in North America, where fast food consumption is high, there is a greater demand for digestive remedies that target issues such as acid reflux and indigestion. In South America, where traditional diets are rich in fiber and fermented foods, there is a greater demand for probiotic products to maintain gut health.

Underlying macroeconomic factors: The growing Digestives & Intestinal Remedies market in the Americas can also be attributed to several macroeconomic factors. Firstly, the region has a large and aging population, which is more prone to digestive issues. As the population continues to age, the demand for digestive remedies is expected to increase. Secondly, there has been a rise in disposable income in many countries in the Americas, allowing individuals to spend more on healthcare and wellness products. Lastly, the increasing prevalence of digestive disorders such as irritable bowel syndrome and gastroesophageal reflux disease has also contributed to the growth of the market.In conclusion, the Digestives & Intestinal Remedies market in Americas is witnessing growth due to customer preferences for natural and herbal remedies, the popularity of probiotics and digestive enzymes, local dietary habits and lifestyles, as well as underlying macroeconomic factors such as an aging population and rising disposable income.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.